ArticleChemPlusChem2025
Monitoring Receptor Clustering by Aggregation-Induced Emission.
Article in ChemPlusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monitoring Receptor Clustering by Aggregation-Induced Emission.ChemPlusChem · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study introduces a simple signal transduction system that mimics the receptor tyrosine kinase mechanism by employing amphiphilic receptors embedded in lipid bilayers. The designed receptors carry bisphosphonate head groups and feature aggregation-induced emission enhancement (AIEE) properties. Upon addition of polyammonium messengers, they undergo ligand-induced dimerization or clustering inside the membrane. Steric restriction of intramolecular motion in the AIE luminophores sends out a fluorescence signal. Systematic comparative studies highlight the impact of receptor design, lipid environment and messenger properties on the efficiency, kinetics, and strength of signal transduction. These findings provide new insight into the interplay between receptor aggregation and membrane organization in controlling fluorescence-based signaling systems. Practical perspectives and inherent limitations are critically discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.